TSHA
Taysha Gene Therapies Inc
4.70$
-2.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 99.4% | 8.9% | 14.9% | 11.7% | |
| – | – | – | 0.6% | 100.0% | 100.0% | 100.0% | |
| – | – | – | 3,643.8% | 367.5% | 792.0% | 884.1% | |
| – | – | – | 1,493.2% | 194.5% | 347.4% | 346.5% | |
| – | – | – | 5,037.6% | 568.8% | 1,197.6% | 1,230.6% | |
| – | – | – | -5,037.1% | -468.8% | -1,097.6% | -1,130.6% | |
| – | – | – | 151.8% | 32.3% | 1.2% | 0.6% | |
| – | – | – | -6,635.3% | -722.1% | -1,071.6% | -1,115.3% | |
| – | – | – | 142.6% | 7.8% | -1,071.6% | – | |
| – | – | – | -6,635.3% | -722.1% | -1,071.6% | -1,115.3% | |
| – | – | – | -6,384.1% | -680.8% | -1,055.5% | -1,102.9% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.